BACKGROUND Pneumatic dilatation or intrasphincteric botulinum toxin injection provide effective symptom relief for patients with achalasia. Although intrasphincteric botulinum toxin injection is simple and safe, its efficacy may be short-lived. Pneumatic dilatation lasts longer, but esophageal perforation is a risk. We compared treatment costs for pneumatic dilatation and intrasphincteric botul...

background: we aimed to study the curative effects of botulinum a toxin (btx-a) on the treatment of post-herpetic neuralgia (pnh). methods: we enrolled 58 pnh patients and treated them with hypodermic injection of btx-a in xiangyang no.1 people’s hospital, hubei university of medicine, hubei, china. we measured and compared the visual analog score (vas), neuropathy pain scale (nps), quality of ...

our aim was to evaluate the short and long term efficacy of botulinum toxin therapy in iranian patients with achalasia. in a randomized, double blind trial, 20 patients with achalasia, referring to imam khomeini hospital, received either 80 units of botulinum toxin (bt) or placebo (pl) from 1995 to 1998. two weeks later, the response to treatment was assessed on the basis of changes in the symp...

A new technique for the treatment of diplopia secondary to cosmetic botulinum toxin A use is described. In this interventional case reports, two consecutive patients who developed diplopia after periocular cosmetic use of botulinum toxin A were treated with intramuscular botulinum toxin A injection into the antagonist extraocular muscle. Diplopia resolved in both patients in less than 1 week wi...

purpose : the aim of this study is to evaluate the effectiveness of intraoperative botulinum toxin-a (bta) injection as an adjunct to the surgical treatment of large-angle esotropia or exotropia. methods : thirteen patients were included in this interventional case series study. mean age of the patients was 23.31±13.29 years (range: 5-43 years). of these 13 patients, 6 were exotropic and 7 were...

background: achalasia is the most recognized esophageal motor disorder with an unknown etiology. symptoms rather than physical findings are hallmarks of the disease. modalilies for treatment include pharmacologic, botulinum toxin injection, pneumatic dilation and surgery. materials and methods: to review the diagnostic and therapeutic options currently available for achalasia. a medline search ...

In this Practice article by Antony Smith and colleagues (BMJ 2013;347:f5170, doi:10.1136/bmj.f5170), the section on use of botulinum toxin A for treating overactive bladder wrongly stated that botulinum toxin type A did not have a UK marketing authorisation for this indication. It should have stated: “At the time of publication (September 2013), most botulinum toxin type A preparations did not ...

effects of single versus repeated injection of botulinum toxin in orofacial formalin test in rats. Abstract Long-term effectiveness and repeated administration of botulinum toxin A are the basis for its use in both neuromuscular disorders and certain painful conditions. Botulinum toxin A has been recently approved for migraine treatment, and its off-label use extends to other craniofacial pain ...

Botulinum toxin is significantly associated with decreased spasticity, increased range of motion and improved upper extremity function. Botulinum toxin in combination with electrical stimulation improves upper extremity function. Deinnervation of the subscapularis muscle using botulinum toxin may reduce shoulder pain and improve passive range of motion, more so than deinervation of the pectoral...